All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
HONG KONG – Yet another prominent Chinese biopharma company may be going private, saying goodbye to a U.S. stock market that is much less welcoming that it once was.
